MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Use with caution

Carbamazepine 200mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 200mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 200mg tablets (Crescent Pharma Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 200mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 200mg tablets (Medihealth (Northern) Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 200mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 200mg tablets (Medreich Plc)

Explore other Carbamazepine formulations Explore other Carbamazepine 200mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 200mg tablets (Noumed Life Sciences Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 200mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 400mg modified-release tablets (Drugsrus Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 400mg modified-release tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container.

Provenance

This compatibility recommendation is derived from Tegretol Prolonged Release 400mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 400mg tablets (A A H Pharmaceuticals Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 400mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 400mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 400mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 400mg tablets (Crescent Pharma Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 400mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 400mg tablets (Medihealth (Northern) Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 400mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 400mg tablets (Medreich Plc)

Explore other Carbamazepine formulations Explore other Carbamazepine 400mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd).

Use with caution

Carbamazepine 400mg tablets (Noumed Life Sciences Ltd)

Explore other Carbamazepine formulations Explore other Carbamazepine 400mg tablets suppliers

Stability Notes

Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd).

No Stability Information

Carbidopa 25mg tablets (Special Order)

Explore other Carbidopa formulations Explore other Carbidopa 25mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Carbimazole 10mg tablets (A A H Pharmaceuticals Ltd)

Explore other Carbimazole formulations Explore other Carbimazole 10mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Carbimazole 10mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Carbimazole formulations Explore other Carbimazole 10mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.
Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.